NOVO B — Novo Nordisk A/S Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeLarge CapFalling Star

Annual balance sheet for Novo Nordisk A/S, fiscal year end - December 31st, DKK millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	16,362	23,116	29,373	25,441	26,065
Net Total Accounts Receivable
Net Total Receivables	46,799	57,505	75,261	87,414	89,186
Total Inventory
Total Other Current Assets
Total Current Assets	85,595	108,194	139,646	160,897	172,453
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	55,362	66,671	90,961	162,488	208,378
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	194,508	241,257	314,486	465,795	542,902
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	99,516	120,940	169,655	217,528	215,661
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	123,762	157,771	207,925	322,309	348,855
Common Stock
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	70,746	83,486	106,561	143,486	194,047
Total Liabilities & Shareholders' Equity	194,508	241,257	314,486	465,795	542,902
Total Common Shares Outstanding